<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">YM</journal-id><journal-title-group><journal-title>Yangtze Medicine</journal-title></journal-title-group><issn pub-type="epub">2475-7330</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ym.2021.52015</article-id><article-id pub-id-type="publisher-id">YM-108473</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Bioinformatics Analysis Revealed Potential Tumor Suppressors (KLF4/CGN), Oncogenes (SHH/LIF) and Biomarkers of Asian Stomach Adenocarcinoma
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yang</surname><given-names>Zhou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yingying</surname><given-names>Wang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Junting</surname><given-names>Cheng</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ying</surname><given-names>Zhang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wenqi</surname><given-names>Cai</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ziwen</surname><given-names>Han</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Moyu</surname><given-names>Wang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Qi</surname><given-names>Huang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Xiaochun</surname><given-names>Peng</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hongwu</surname><given-names>Xin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Department of Pathophysiology, School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, China</addr-line></aff><aff id="aff1"><addr-line>Laboratory of Oncology, Center for Molecular Medicine, School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, China</addr-line></aff><aff id="aff2"><addr-line>Department of Biochemistry and Molecular Biology, School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, China</addr-line></aff><pub-date pub-type="epub"><day>15</day><month>04</month><year>2021</year></pub-date><volume>05</volume><issue>02</issue><fpage>141</fpage><lpage>156</lpage><history><date date-type="received"><day>3,</day>	<month>December</month>	<year>2020</year></date><date date-type="rev-recd"><day>12,</day>	<month>April</month>	<year>2021</year>	</date><date date-type="accepted"><day>15,</day>	<month>April</month>	<year>2021</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Stomach adenocarcinoma (STAD) is the fifth most prevalent cancer and the third leading cause of cancer-related death in the world and is more common in Asia than in most Western countries. There is an urgent need to identify potential novel oncogenes and tumor suppressor genes, and biomarkers for STAD. 6652 differentially expressed genes were identified between STAD and normal samples based on the transcriptome data analysis of the TCGA and GEO databases. 13 key modules were identified in STAD by WGCNA analysis. 293 potential STAD associated genes were identified from intersection by Venn Diagram. The 293 intersected genes were enriched in cell cortex and infection by GO and KEGG analysis. 10 hub genes were identified from PPI and Cytoscape analyses of the intersected genes. KLF4/CGN low and SHH/LIF high expression were associated with short overall survival of Asian STAD patients. Bioinformatics analysis revealed potential novel tumor suppressors (KLF4/CGN), oncogenes (SHH/LIF) and biomarkers for diagnosis, therapy and prognosis of STAD, specifically for Asian patients.
 
</p></abstract><kwd-group><kwd>WGCNA (Weighted Correlation Network Analysis)</kwd><kwd> Tumor Suppressors</kwd><kwd> Oncogenes</kwd><kwd> Stomach Adenocarcinoma (STAD)</kwd><kwd> Hub Gene</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>More than one million people worldwide are diagnosed with gastric adenocarcinoma or stomach adenocarcinoma (STAD) each year. STAD is the fifth most prevalent cancer and the third leading cause of cancer-related death in the world. Gastric cancer is more common in Asia than in most Western countries. The incidence in East Asia is about 50 cases per 100,000 people, about 10 times more than that in North America [<xref ref-type="bibr" rid="scirp.108473-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.108473-ref2">2</xref>]. There is an urgent need to identify potential novel oncogenes and tumor suppressor genes, and biomarkers of diagnosis, therapy and prognosis specifically for Asian STAD.</p><p>Weighted correlation network analysis (WGCNA) [<xref ref-type="bibr" rid="scirp.108473-ref3">3</xref>] is a data reduction and unsupervised classification method. It simplifies the interpretation of many gene responses to multiple synthetic genomes (or modules). The net establishes a link between genes whose expression is related. There will be connections between genes, depending on the value of the correlation (weight). Connectivity between genes is then interpreted as distance, with which genes are grouped into modules. This is the way to reduce many genes to several clusters, the expression of which is quantified by Eigengenes (the first principal component in the module). It assumes that highly related genes in the module are involved in a common biological process.</p><p>At present, there are only 4 articles in PubMed in which WGCNA was used to study the gastric cancer transcriptome and none of the 4 articles specifically studied the Asian human STAD transcriptome [<xref ref-type="bibr" rid="scirp.108473-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.108473-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.108473-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.108473-ref7">7</xref>]. Here we used WGCNA together with other bioinformatic tools to identify potential novel oncogenes, tumor suppressor genes, and biomarkers of diagnosis, therapy and prognosis specifically for Asian STAD.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Installation of R and Perl</title><p>R x64 4.03 language installation package were downloaded from https://www.r-project.org/, Perl installation package downloaded from https://www.perl.org/, and they were installed as instructed.</p></sec><sec id="s2_2"><title>2.2. Datasets from TCGA</title><p>With filters of Cases (Stomach, TCGA, TCGA-STAD, Adenomas and Adeno Carcinomas and Asian) and Files (Transcriptome Profiling, Gene Expression Quantification, HTSeq-Counts and Txt), 74 samples (7 normal tissues and 67 tumors) were filtered out from the TCGA database (https://portal.gdc.cancer.gov/) and the required files were exported via Cart. The exported files were decompressed, and the 74 samples were processed through Perl to merge them together and calculated to get a Matrix file. The matrix file ENSG ID then was converted into Symbol ID by R language.</p><p>With filters of Cases (Stomach, TCGA, TCGA-STAD, Adenomas and Adeno Carcinomas and Asian) and Files (Clinical and Bcr xml), then clinical datasets of 443 samples were obtained from TCGA. Clinical information of gene ID, futime, fustat, age, gender, grade, stage, T, M and N was obtained through Perl.</p></sec><sec id="s2_3"><title>2.3. Datasets from GEO</title><p>The Expression Profiling by Array (Series GSE 54129) was obtained from GEO (https://www.ncbi.nlm.nih.gov/). We contained information on 111 human gastric cancer tissues and 21 non-cancerous gastric tissues, which were collected in Ruijin Hospital, SJTU, China. Through Perl processing of the GEO file, we obtained one probe, one matrix file, and one annotation file.</p></sec><sec id="s2_4"><title>2.4. Differential Expression Analysis</title><p>The differential expression analysis environment was constructed with four packages including limma, edgeR, pheatmap and ggplot2 through R software to output the analysis results. Take logFC filter conditions as logfcfilter = 1; After correction, the P value filtering condition was set as fdrFilter = 0.05. TCGA datasets and GEO datasets were analyzed, respectively.</p></sec><sec id="s2_5"><title>2.5. Construction of WGCNA and Identification of Important Modules</title><p>Data was processed using R 4.0.3 software. To ensure the reliability of the network construction, the abnormal samples were deleted. Pearson correlation coefficient was calculated to assess the similarity of gene expression profiles, and then the correlation coefficient between genes was weighted by a power function to obtain a scale-free network. In terms of co-expression, gene modules are densely interconnected gene clusters. WGCNA uses hierarchical clustering to identify gene modules and colors to indicate modules. Dynamic tree cutting was used to identify different modules. In the module selection process, the adjacency matrix (a measure of topological similarity) was converted into a topological covering matrix (TOM, no graph was output due to the limited function of the computer), and the modules were detected by clustering analysis.</p><p>The WGCNA and limma packages of R were used. The minimum gene module size was set to 50 to obtain modules of appropriate size and the threshold for merging similar modules was set to 0.25. TCGA datasets and GEO datasets were analyzed, respectively.</p></sec><sec id="s2_6"><title>2.6. Venn Diagram</title><p>TCGA differential expression analysis results, GEO differential expression analysis results, TCGA turquoise module and GEO black module were made into Venn Diagram by Venn Diagram package in R, and the intersection gene data text of the four kinds of data were output at the same time.</p></sec><sec id="s2_7"><title>2.7. GO (Gene Ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) Enrichment Analysis</title><p>Intersection gene data text showed gene by symbol ID. We translated it into entrezID with R’s org.Hs.eg.db package. Then the enrichment analysis was done by R to library clusterProfiler, org.Hs.eg.db, enrichplot and ggplot2 packages. p value filter condition was set as p value filter = 0.05; the adjusted p-value filter condition was set as q value Filter = 1.</p></sec><sec id="s2_8"><title>2.8. PPI (Protein Interaction Network) Analysis</title><p>On the website https://string-db.org/, we input the intersection genes of Venn, selected species, and then got the network diagram of protein interaction. We highlighted the connection of these genes by setting the minimum required interaction score. It can also set medium confidence (0.400) or hide disconnected nodes in the network. We output proteins interactions file and protein interaction diagram.</p></sec><sec id="s2_9"><title>2.9. Cytoscape</title><p>We installed java, then installed Cytoscape. We imported the files obtained from PPI processing into Cytoscape to obtain hub genes.</p></sec><sec id="s2_10"><title>2.10. HPA</title><p>The obtained ten hub genes were introduced into the http://www.proteinatlas.org/, to obtain immunohistochemical images related to the target genes and diseases.</p></sec><sec id="s2_11"><title>2.11. Survival and Clinical Analysis</title><p>Overall survival of STAD patients was analyzed using the Kaplan Meier plot (http://kmplot.com).</p></sec></sec><sec id="s3"><title>3. Result</title><sec id="s3_1"><title>3.1. 6652 Differentially Expressed Genes Were Identified between STAD and Normal Samples</title><p>A total of 4859 differentially expressed genes from TCGA and 1793 differentially expressed genes from GEO were identified between STAD and normal samples as shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>(a) and <xref ref-type="fig" rid="fig1">Figure 1</xref>(b) (TCGA) and <xref ref-type="fig" rid="fig1">Figure 1</xref>(c) and <xref ref-type="fig" rid="fig1">Figure 1</xref>(d) (GEO).</p></sec><sec id="s3_2"><title>3.2. 13 key Modules Were Identified in STAD by WGCNA Analysis</title><p>The first 25% differentially expressed genes in TCGA and GEO data were separately used for cluster analysis through WGCNA package. Hierarchical clustering trees were constructed using the gene expression data with the height threshold limit and screen out outliers. The rest of the data was used to construct and weight the co-expression network. To determine the optimal value of soft threshold (power), the analysis needs were made in a certain range and the scale-free condition. When the power value was set to 1 and 8 (<xref ref-type="fig" rid="fig2">Figure 2</xref>(a)), the connectivity between genes in the network satisfied the scale-free network distribution. By combining the modules with higher similarity of characteristic</p><p>memes (MEME, a WGCNA term for a module with the same characteristics) using the dynamic mixing shearing method, 5 and 8 MEME modules were finally obtained for TCGA (<xref ref-type="fig" rid="fig2">Figure 2</xref>(b)) and GEO (<xref ref-type="fig" rid="fig2">Figure 2</xref>(c)) data sets, respectively. We found that the expression of the genes in turquoise modules of TCGA samples and in black modules of GEO samples have the greatest correlation with the tumor tissues (<xref ref-type="fig" rid="fig2">Figure 2</xref>(d)).</p></sec><sec id="s3_3"><title>3.3. 293 Potential STAD Associated Genes Were Identified from Intersection by Venn Diagram</title><p>To reduce the false positive rate of the results, the Venn diagram of the above four data sets (TCGA turquoise module, GEO black module, TCGA differentially expressed genes and GEO differentially expressed genes) was used for intersection. There are 293 genes that are intersected in all 4 groups, and pictures and text files were output (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p></sec><sec id="s3_4"><title>3.4. The 293 Intersected Genes Were Enriched in Cell Cortex and Infection by GO and KEGG Analysis</title><p>GO and KEGG analyses were carried out to explore their biological function of the 293 intersected genes identified by Venn Diagram. GO analysis showed that these genes are mainly involved in the processes of cell cortex, secretory granule lumen, carbohydrate binding and actin binding. KEGG analysis showed that these genes were highly correlated with Hepatitis C, pathogenic Escherichia coli infection, amino sugar and nucleotide sugar metabolism, complement and coastal cascades, and Histidine metabolism (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig4">Figure 4</xref>).</p></sec><sec id="s3_5"><title>3.5. 10 Hub Genes Were Identified from PPI and Cytoscape Analyses of the Intersected Genes</title><p>PPI analysis of the 293 intersected genes identified by Venn Diagram sorted out 354 pairwise links and deleted the genes that were not connected with the subject network (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Then we imported the interactive file obtained from the PPI analysis into Cytoscape to construct a gene network and screened out 10 hub genes (KLF4, CGN, SHH, LIF, GATA6, FOXA2, OCLN, FOXA1, CLDN1 and NQO1) according to their degree of associations (<xref ref-type="table" rid="table2">Table 2</xref> and <xref ref-type="table" rid="table3">Table 3</xref>, <xref ref-type="fig" rid="fig5">Figure 5</xref>). Among the 10 hub genes, KLF4 and CGN expression was decreased while other 8 gene expression was increased in STAD tumors compared to normal tissues (<xref ref-type="table" rid="table3">Table 3</xref>). When we imported into the HPA official website, immunohistochemical images of malignant gastric cancer tissues verified the expression of these hub genes.</p></sec><sec id="s3_6"><title>3.6. KLF4/CGN Low and SHH/LIF High Expression Were Associated with Short Overall Survival of Asian STAD Patients</title><p>Interestingly, using the Kaplan Meier plot, we found that SHH/LIF high expression among tumors was associated with short overall survival of Asian STAD patients, while low expression of KLF4/CGN and the other 6 hub genes among tumors was associated with short overall survival of Asian STAD patients (<xref ref-type="table" rid="table4">Table 4</xref> and <xref ref-type="fig" rid="fig6">Figure 6</xref>). The association of the gene expression among tumors and</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> The most significant biological function of the 293 STAD associated Venn intersection gene from KEGG</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >ID</th><th align="center" valign="middle" >Description</th><th align="center" valign="middle" >Gene Ratio</th><th align="center" valign="middle" >Bg Ratio</th><th align="center" valign="middle" >P value</th><th align="center" valign="middle" >P. adjust</th><th align="center" valign="middle" >q value</th><th align="center" valign="middle" >Gene ID</th><th align="center" valign="middle" >Count</th></tr></thead><tr><td align="center" valign="middle" >hsa00980</td><td align="center" valign="middle" >Metabolism of xenobiotics by cytochrome P450</td><td align="center" valign="middle" >6/129</td><td align="center" valign="middle" >78/8075</td><td align="center" valign="middle" >0.001484</td><td align="center" valign="middle" >0.103158</td><td align="center" valign="middle" >0.10313</td><td align="center" valign="middle" >AKR1C1/AKR7A3/CBR1/CYP3A5/EPHX1/GSTM2</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >hsa00512</td><td align="center" valign="middle" >Mucin type O-glycan biosynthesis</td><td align="center" valign="middle" >4/129</td><td align="center" valign="middle" >32/8075</td><td align="center" valign="middle" >0.001581</td><td align="center" valign="middle" >0.103158</td><td align="center" valign="middle" >0.10313</td><td align="center" valign="middle" >GALNT5/GALNT6/GALNT7/GCNT1</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >hsa05204</td><td align="center" valign="middle" >Chemical carcinogenesis</td><td align="center" valign="middle" >6/129</td><td align="center" valign="middle" >83/8075</td><td align="center" valign="middle" >0.002044</td><td align="center" valign="middle" >0.103158</td><td align="center" valign="middle" >0.10313</td><td align="center" valign="middle" >CBR1/CYP2C18/CYP3A5/EPHX1/GSTM2/NAT1</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >hsa00480</td><td align="center" valign="middle" >Glutathione metabolism</td><td align="center" valign="middle" >5/129</td><td align="center" valign="middle" >57/8075</td><td align="center" valign="middle" >0.002074</td><td align="center" valign="middle" >0.103158</td><td align="center" valign="middle" >0.10313</td><td align="center" valign="middle" >CHAC2/G6PD/GPX2/GSTM2/IDH1</td><td align="center" valign="middle" >5</td></tr><tr><td align="center" valign="middle" >hsa00514</td><td align="center" valign="middle" >Other types of O-glycan biosynthesis</td><td align="center" valign="middle" >4/129</td><td align="center" valign="middle" >47/8075</td><td align="center" valign="middle" >0.006522</td><td align="center" valign="middle" >0.259581</td><td align="center" valign="middle" >0.259512</td><td align="center" valign="middle" >GALNT5/GALNT6/GALNT7/PLOD3</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >hsa05160</td><td align="center" valign="middle" >Hepatitis C</td><td align="center" valign="middle" >7/129</td><td align="center" valign="middle" >157/8075</td><td align="center" valign="middle" >0.012718</td><td align="center" valign="middle" >0.381891</td><td align="center" valign="middle" >0.38179</td><td align="center" valign="middle" >CD81/CLDN1/CLDN23/IRF3/OAS1/OCLN/TLR3</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >hsa05130</td><td align="center" valign="middle" >Pathogenic Escherichia coli infection</td><td align="center" valign="middle" >8/129</td><td align="center" valign="middle" >197/8075</td><td align="center" valign="middle" >0.013433</td><td align="center" valign="middle" >0.381891</td><td align="center" valign="middle" >0.38179</td><td align="center" valign="middle" >BAIAP2L1/CLDN1/CLDN23/IL18/ MYO5B/MYO5C/OCLN/TUBB2A</td><td align="center" valign="middle" >8</td></tr><tr><td align="center" valign="middle" >hsa00520</td><td align="center" valign="middle" >Amino sugar and nucleotide sugar metabolism</td><td align="center" valign="middle" >3/129</td><td align="center" valign="middle" >48/8075</td><td align="center" valign="middle" >0.040911</td><td align="center" valign="middle" >0.926281</td><td align="center" valign="middle" >0.926036</td><td align="center" valign="middle" >CYB5R3/GFPT1/GMDS</td><td align="center" valign="middle" >3</td></tr><tr><td align="center" valign="middle" >hsa04610</td><td align="center" valign="middle" >Complement and coagulation cascades</td><td align="center" valign="middle" >4/129</td><td align="center" valign="middle" >85/8075</td><td align="center" valign="middle" >0.046745</td><td align="center" valign="middle" >0.926281</td><td align="center" valign="middle" >0.926036</td><td align="center" valign="middle" >BDKRB1/F5/PLAU/SERPINA1</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >hsa00340</td><td align="center" valign="middle" >Histidine metabolism</td><td align="center" valign="middle" >2/129</td><td align="center" valign="middle" >22/8075</td><td align="center" valign="middle" >0.047501</td><td align="center" valign="middle" >0.926281</td><td align="center" valign="middle" >0.926036</td><td align="center" valign="middle" >ALDH2/MAOA</td><td align="center" valign="middle" >2</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> The 10 hub genes filtered based on MCC information</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Node name</th><th align="center" valign="middle" >MCC</th><th align="center" valign="middle" >DMNC</th><th align="center" valign="middle" >MNC</th><th align="center" valign="middle" >Degree</th><th align="center" valign="middle" >EPC</th><th align="center" valign="middle" >Bottle Neck</th><th align="center" valign="middle" >Ec Centricity</th><th align="center" valign="middle" >Closeness</th><th align="center" valign="middle" >Radiality</th><th align="center" valign="middle" >Betweenness</th><th align="center" valign="middle" >Stress</th><th align="center" valign="middle" >Clustering Coefficient</th></tr></thead><tr><td align="center" valign="middle" >KLF4</td><td align="center" valign="middle" >73</td><td align="center" valign="middle" >0.35915</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >58.277</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >0.11257</td><td align="center" valign="middle" >63.44286</td><td align="center" valign="middle" >6.21607</td><td align="center" valign="middle" >2416.518</td><td align="center" valign="middle" >8984</td><td align="center" valign="middle" >0.32727</td></tr><tr><td align="center" valign="middle" >GATA6</td><td align="center" valign="middle" >63</td><td align="center" valign="middle" >0.4082</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >54.523</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.0985</td><td align="center" valign="middle" >53.76071</td><td align="center" valign="middle" >5.72936</td><td align="center" valign="middle" >597.1098</td><td align="center" valign="middle" >2556</td><td align="center" valign="middle" >0.38889</td></tr><tr><td align="center" valign="middle" >SHH</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >0.37904</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >55.244</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >0.11257</td><td align="center" valign="middle" >59.64286</td><td align="center" valign="middle" >6.03529</td><td align="center" valign="middle" >1517.783</td><td align="center" valign="middle" >4498</td><td align="center" valign="middle" >0.23636</td></tr><tr><td align="center" valign="middle" >FOXA2</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >0.37904</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >56.063</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.0985</td><td align="center" valign="middle" >56.77738</td><td align="center" valign="middle" >5.91477</td><td align="center" valign="middle" >539.4949</td><td align="center" valign="middle" >2704</td><td align="center" valign="middle" >0.46429</td></tr><tr><td align="center" valign="middle" >OCLN</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >0.32929</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >55.116</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >0.11257</td><td align="center" valign="middle" >61.89286</td><td align="center" valign="middle" >6.08628</td><td align="center" valign="middle" >3128.249</td><td align="center" valign="middle" >9986</td><td align="center" valign="middle" >0.16667</td></tr><tr><td align="center" valign="middle" >LIF</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >0.47549</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >52.922</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.11257</td><td align="center" valign="middle" >56.45952</td><td align="center" valign="middle" >5.9704</td><td align="center" valign="middle" >639.8622</td><td align="center" valign="middle" >2770</td><td align="center" valign="middle" >0.47619</td></tr><tr><td align="center" valign="middle" >FOXA1</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >0.2864</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >55.625</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >0.0985</td><td align="center" valign="middle" >58.49405</td><td align="center" valign="middle" >5.95186</td><td align="center" valign="middle" >1700.16</td><td align="center" valign="middle" >6308</td><td align="center" valign="middle" >0.26667</td></tr><tr><td align="center" valign="middle" >CLDN1</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >0.38039</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >49.53</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.11257</td><td align="center" valign="middle" >54.16905</td><td align="center" valign="middle" >5.79889</td><td align="center" valign="middle" >726.2893</td><td align="center" valign="middle" >2198</td><td align="center" valign="middle" >0.32143</td></tr><tr><td align="center" valign="middle" >CGN</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >0.56839</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >46.468</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0.0985</td><td align="center" valign="middle" >51.07262</td><td align="center" valign="middle" >5.53931</td><td align="center" valign="middle" >1034.018</td><td align="center" valign="middle" >2754</td><td align="center" valign="middle" >0.25</td></tr><tr><td align="center" valign="middle" >NQO1</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >0.36588</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >43.906</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0.13134</td><td align="center" valign="middle" >55.8</td><td align="center" valign="middle" >5.83134</td><td align="center" valign="middle" >2021.798</td><td align="center" valign="middle" >5364</td><td align="center" valign="middle" >0.27778</td></tr></tbody></table></table-wrap><p>Note: maximal clique centrality (MCC); density of maximum neighborhood component (DMNC); maximum neighborhood component (MNC); edge percolated component (EPC).</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Differential expression of the 10 hub genes in STAD tumors verse normal tissues (GEOdiff)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >ID</th><th align="center" valign="middle" >logFC</th><th align="center" valign="middle" >Ave Expr</th><th align="center" valign="middle" >t</th><th align="center" valign="middle" >P. Value</th><th align="center" valign="middle" >adj. P. Val</th><th align="center" valign="middle" >B</th></tr></thead><tr><td align="center" valign="middle" >KLF4</td><td align="center" valign="middle" >−1.47302</td><td align="center" valign="middle" >6.06431</td><td align="center" valign="middle" >−3.1081</td><td align="center" valign="middle" >0.00265</td><td align="center" valign="middle" >0.007416</td><td align="center" valign="middle" >−2.49024</td></tr><tr><td align="center" valign="middle" >GATA6</td><td align="center" valign="middle" >2.097037</td><td align="center" valign="middle" >5.957883</td><td align="center" valign="middle" >4.016353</td><td align="center" valign="middle" >0.000138</td><td align="center" valign="middle" >0.000587</td><td align="center" valign="middle" >0.289208</td></tr><tr><td align="center" valign="middle" >SHH</td><td align="center" valign="middle" >3.041936</td><td align="center" valign="middle" >2.593291</td><td align="center" valign="middle" >3.930826</td><td align="center" valign="middle" >0.000185</td><td align="center" valign="middle" >0.00076</td><td align="center" valign="middle" >0.00668</td></tr><tr><td align="center" valign="middle" >FOXA2</td><td align="center" valign="middle" >4.817927</td><td align="center" valign="middle" >4.158278</td><td align="center" valign="middle" >6.301899</td><td align="center" valign="middle" >1.77E−08</td><td align="center" valign="middle" >2.65E−07</td><td align="center" valign="middle" >8.97395</td></tr><tr><td align="center" valign="middle" >OCLN</td><td align="center" valign="middle" >3.418704</td><td align="center" valign="middle" >4.562556</td><td align="center" valign="middle" >6.173057</td><td align="center" valign="middle" >3.04E−08</td><td align="center" valign="middle" >4.22E−07</td><td align="center" valign="middle" >8.441581</td></tr><tr><td align="center" valign="middle" >LIF</td><td align="center" valign="middle" >2.095345</td><td align="center" valign="middle" >3.932531</td><td align="center" valign="middle" >5.407506</td><td align="center" valign="middle" >7.15E−07</td><td align="center" valign="middle" >6.35E−06</td><td align="center" valign="middle" >5.361607</td></tr><tr><td align="center" valign="middle" >FOXA1</td><td align="center" valign="middle" >4.845426</td><td align="center" valign="middle" >4.857299</td><td align="center" valign="middle" >6.639157</td><td align="center" valign="middle" >4.19E−09</td><td align="center" valign="middle" >7.78E−08</td><td align="center" valign="middle" >10.38263</td></tr><tr><td align="center" valign="middle" >CLDN1</td><td align="center" valign="middle" >3.484039</td><td align="center" valign="middle" >5.44208</td><td align="center" valign="middle" >4.770593</td><td align="center" valign="middle" >8.71E−06</td><td align="center" valign="middle" >5.46E−05</td><td align="center" valign="middle" >2.938582</td></tr><tr><td align="center" valign="middle" >CGNL1</td><td align="center" valign="middle" >−2.66988</td><td align="center" valign="middle" >2.885747</td><td align="center" valign="middle" >−4.12225</td><td align="center" valign="middle" >9.5E−05</td><td align="center" valign="middle" >0.000426</td><td align="center" valign="middle" >0.644452</td></tr><tr><td align="center" valign="middle" >NQO1</td><td align="center" valign="middle" >1.778712</td><td align="center" valign="middle" >7.197352</td><td align="center" valign="middle" >2.88561</td><td align="center" valign="middle" >0.005084</td><td align="center" valign="middle" >0.012958</td><td align="center" valign="middle" >−3.08934</td></tr></tbody></table></table-wrap><p>LogFC means log (expression in cancer/expression in normal tissue). The higher the value, the higher the expression levels in cancer tissues are. Minus of LogFC means the expression is lower in cancer tissues compared to that in normal tissues from GEO datasets series GSE 54129.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> The survival times of the 10 hub genes</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Gene</th><th align="center" valign="middle" >Low expression cohort (months)</th><th align="center" valign="middle" >High expression cohort (months)</th><th align="center" valign="middle" >P value</th></tr></thead><tr><td align="center" valign="middle" >KLF4</td><td align="center" valign="middle" >21.2</td><td align="center" valign="middle" >33.27</td><td align="center" valign="middle" >0.00028</td></tr><tr><td align="center" valign="middle" >GATA6</td><td align="center" valign="middle" >22.2</td><td align="center" valign="middle" >40.7</td><td align="center" valign="middle" >4.2e−08</td></tr><tr><td align="center" valign="middle" >SHH</td><td align="center" valign="middle" >41.2</td><td align="center" valign="middle" >21.6</td><td align="center" valign="middle" >3.3e−08</td></tr><tr><td align="center" valign="middle" >FOXA2</td><td align="center" valign="middle" >24.9</td><td align="center" valign="middle" >29.8</td><td align="center" valign="middle" >0.059</td></tr><tr><td align="center" valign="middle" >OCLN</td><td align="center" valign="middle" >28.03</td><td align="center" valign="middle" >85.6</td><td align="center" valign="middle" >6.6e−07</td></tr><tr><td align="center" valign="middle" >LIF</td><td align="center" valign="middle" >40.2</td><td align="center" valign="middle" >22.87</td><td align="center" valign="middle" >3.3e−06</td></tr><tr><td align="center" valign="middle" >FOXA1</td><td align="center" valign="middle" >26.7</td><td align="center" valign="middle" >33.27</td><td align="center" valign="middle" >0.016</td></tr><tr><td align="center" valign="middle" >CLDN1</td><td align="center" valign="middle" >41.2</td><td align="center" valign="middle" >67.1</td><td align="center" valign="middle" >0.084</td></tr><tr><td align="center" valign="middle" >CGN</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >77.2</td><td align="center" valign="middle" >4.9e−05</td></tr><tr><td align="center" valign="middle" >NQO1</td><td align="center" valign="middle" >25.2</td><td align="center" valign="middle" >36.4</td><td align="center" valign="middle" >0.00034</td></tr></tbody></table></table-wrap><p>overall survival are consistent with the KLF4/CGN low expression or SHH/LIF high expression in the STAD tumors compared to normal tissues (<xref ref-type="table" rid="table3">Table 3</xref>). Our findings support that KLF4/CGN is potential tumor suppressor and SHH/LIF is potential oncogene for STAD of Asian patients.</p></sec></sec><sec id="s4"><title>4. Discussion and Conclusion</title><p>STAD is a kind of high incidence and mortality tumor in adults, especially in Asian, and there is an urgent need to identify potential novel oncogenes, tumor suppressor genes, and biomarkers of diagnosis, therapy and prognosis, specifically for Asian STAD. In this study, the gene expression data of the STAD transcriptome were analyzed, and a total of 4859 differentially expressed genes from TCGA and 1793 genes from GEO were identified in STAD, followed by identification of the five modules of TCGA and eight modules of GEO. These differentially expressed genes and the tumor’s associated module genes were subjected to Venn intersection, and 293 intersected genes were obtained. These intersected genes are enriched in a few biological processes and biological functions, such as chemotaxis, inflammatory reactions, angiogenesis, cell cycle, etc., which may be related to the occurrence and development of the cancer. Ten hub genes were screened out from these 293 intersected genes for association analysis with survival in patients with STAD. Our results showed that KLF4/CGN low and SHH/LIF high expression were associated with short overall survival of Asian STAD patients. Our bioinformatics analysis revealed potential novel tumor suppressors (KLF4/CGN) and oncogenes (SHH/LIF) and biomarkers for diagnosis, therapy and prognosis of STAD, specifically for Asian patients [<xref ref-type="bibr" rid="scirp.108473-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.108473-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.108473-ref10">10</xref>].</p><p>In our study, the system biology-based methods, including WGCNA, were used to identify the 10 network hub genes related to STAD, namely KLF4, CGN, LIF, SHH, GATA6, FOXA2, OCLN, FOXA1, CLDN1 and NQO1. While KLF4/CGN low and SHH/LIF high expression were associated with short overall survival of Asian STAD patients, the other 6 hub genes (GATA6, FOXA2, OCLN, FOXA1, CLDN1 and NQO1) were all expressed higher in STAD tumors compared to the normal tissues, but higher expression in tumors showed longer overall survival of STAD patients. The inconsistence may suggest that the 6 hub genes may be passenger genes or expressed as an active compensation to suppress tumor progression. It has been shown that KLF4, CGN, GATA6, FOXA2, OCLN, FOXA1, CLDN1 and NQO1 can inhibit the occurrence and development of tumors [<xref ref-type="bibr" rid="scirp.108473-ref11">11</xref>] - [<xref ref-type="bibr" rid="scirp.108473-ref17">17</xref>], while SHH and LIF promote tumor occurrence and development [<xref ref-type="bibr" rid="scirp.108473-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.108473-ref19">19</xref>]. LIF promotes tumorigenesis and metastasis of breast cancer, Shh Bladder promotes cancer stemness and tumorigenesis. At present, experimental studies on CGN are not found. KLF4 can inhibit proliferation and invasion of breast cancer [<xref ref-type="bibr" rid="scirp.108473-ref20">20</xref>], reduce the impact of chemotherapy on colon cancer cells [<xref ref-type="bibr" rid="scirp.108473-ref21">21</xref>]. As an important signal transduction pathway for the occurrence and development of cancer, SHH has become an important target gene for the treatment of medulloblastoma and pancreatic cancer [<xref ref-type="bibr" rid="scirp.108473-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.108473-ref23">23</xref>]. LIF can be induced by HIF-2α and promotes tumor progression, metastasis, and chemical resistance in a variety of solid tumors [<xref ref-type="bibr" rid="scirp.108473-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.108473-ref25">25</xref>]. The potential novel tumor suppressors and oncogenes and biomarkers identified here need to be further validated.</p><p>Some limitations of our study should be mentioned. First, this was a retrospective design study, not a prospective cohort study. In addition, a large sample size was required to verify our findings. Thirdly, these results may be validated experimentally in future.</p></sec><sec id="s5"><title>Funding</title><p>This work was supported by National Natural Science Foundation of China (81872412).</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Zhou, Y., Wang, Y.Y., Cheng, J.T., Zhang, Y., Cai, W.Q., Han, Z.W., Wang, M.Y., Huang, Q., Peng, X.C. and Xin, H.W. (2021) Bioinformatics Analysis Revealed Potential Tumor Suppressors (KLF4/CGN), Oncogenes (SHH/LIF) and Biomarkers of Asian Stomach Adenocarcinoma. Yangtze Medicine, 5, 141-156. https://doi.org/10.4236/ym.2021.52015</p></sec><sec id="s8"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.108473-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Schumacher, S.E., et al. (2017) Somatic Copy Number Alterations in Gastric Adenocarcinomas among Asian and Western Patients. PLoS ONE, 12, e0176045. https://doi.org/10.1371/journal.pone.0176045</mixed-citation></ref><ref id="scirp.108473-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Syed, I.S., Pedram, A. and Farhat, W.A. (2016) Role of Sonic Hedgehog (Shh) Signaling in Bladder Cancer Stemness and Tumorigenesis. Current Urology Reports, 17, 11. https://doi.org/10.1007/s11934-015-0568-9</mixed-citation></ref><ref id="scirp.108473-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Nagata, T., et al. (2017) KLF4 and NANOG Are Prognostic Biomarkers for Triple-Negative Breast Cancer. Breast Cancer, 24, 326-335. https://doi.org/10.1007/s12282-016-0708-1</mixed-citation></ref><ref id="scirp.108473-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Yadav, S.S., et al. (2019) KLF4 Sensitizes the Colon Cancer Cell HCT-15 to Cisplatin by Altering the Expression of HMGB1 and hTERT. Life Sciences, 220, 169-176. https://doi.org/10.1016/j.lfs.2019.02.005</mixed-citation></ref><ref id="scirp.108473-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Catenacci, D.V., et al. (2015) Randomized Phase Ib/II Study of Gemcitabine plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients with Metastatic Pancreatic Cancer. Journal of Clinical Oncology, 33, 4284-4292. https://doi.org/10.1200/JCO.2015.62.8719</mixed-citation></ref><ref id="scirp.108473-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Samkari, A., White, J. and Packer, R. (2015) SHH Inhibitors for the Treatment of Medulloblastoma. Expert Review of Neurotherapeutics, 15, 763-770. https://doi.org/10.1586/14737175.2015.1052796</mixed-citation></ref><ref id="scirp.108473-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Wu, L., et al. (2015) HIF-2&lt;i&gt;&amp;#945;&lt;/i&gt; Mediates Hypoxia-Induced LIF Expression in Human Colorectal Cancer Cells. Oncotarget, 6, 4406-4417. https://doi.org/10.18632/oncotarget.3017</mixed-citation></ref><ref id="scirp.108473-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, L., et al. (2016) Expression of HIF-2&lt;i&gt;&amp;#945;&lt;/i&gt; and VEGF in Cervical Squamous Cell Carcinoma and Its Clinical Significance. BioMed Research International, 2016, Article ID: 5631935. https://doi.org/10.1155/2016/5631935</mixed-citation></ref><ref id="scirp.108473-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Li, X., et al. (2014) LIF Promotes Tumorigenesis and Metastasis of Breast Cancer through the AKT-mTOR Pathway. Oncotarget, 5, 788-801. https://doi.org/10.18632/oncotarget.1772</mixed-citation></ref><ref id="scirp.108473-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Wang, X., et al. (2020) The Deubiquitinase USP10 Regulates KLF4 Stability and Suppresses Lung Tumorigenesis. Cell Death &amp; Differentiation, 27, 1747-1764. https://doi.org/10.1038/s41418-019-0458-7</mixed-citation></ref><ref id="scirp.108473-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Motea, E.A., et al. (2019) NQO1-Dependent, Tumor-Selective Radiosensitization of Non-Small Cell Lung Cancers. Clinical Cancer Research, 25, 2601-2609. https://doi.org/10.1158/1078-0432.CCR-18-2560</mixed-citation></ref><ref id="scirp.108473-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Martinelli, P., et al. (2017) GATA6 Regulates EMT and Tumour Dissemination, and Is a Marker of Response to Adjuvant Chemotherapy in Pancreatic Cancer. Gut, 66, 1665-1676. https://doi.org/10.1136/gutjnl-2015-311256</mixed-citation></ref><ref id="scirp.108473-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Mahati, S., et al. (2017) miR-29a Suppresses Growth and Migration of Hepatocellular Carcinoma by Regulating CLDN1. Biochemical and Biophysical Research Communications, 486, 732-737. https://doi.org/10.1016/j.bbrc.2017.03.110</mixed-citation></ref><ref id="scirp.108473-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Liu, J., et al. (2018) Coordination of FOXA2 and SIRT6 Suppresses the Hepatocellular Carcinoma Progression through ZEB2 Inhibition. Cancer Management and Research, 10, 391-402. https://doi.org/10.2147/CMAR.S150552</mixed-citation></ref><ref id="scirp.108473-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Concei&amp;#231;&amp;#227;o, A.L., et al. (2017) Downregulation of OCLN and GAS1 in Clear Cell Renal Cell Carcinoma. Oncology Reports, 37, 1487-1496. https://doi.org/10.3892/or.2017.5414</mixed-citation></ref><ref id="scirp.108473-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Adams, E.J., et al. (2019) FOXA1 Mutations Alter Pioneering Activity, Differentiation and Prostate Cancer Phenotypes. Nature, 571, 408-412. https://doi.org/10.1038/s41586-019-1318-9</mixed-citation></ref><ref id="scirp.108473-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Sulahian, R., et al. (2014) An Integrative Analysis Reveals Functional Targets of GATA6 Transcriptional Regulation in Gastric Cancer. Oncogene, 33, 5637-5648. https://doi.org/10.1038/onc.2013.517</mixed-citation></ref><ref id="scirp.108473-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Samadani, A.A., et al. (2019) CDX1/2 and KLF5 Expression and Epigenetic Modulation of Sonic Hedgehog Signaling in Gastric Adenocarcinoma. Pathology &amp; Oncology Research, 25, 1215-1222. https://doi.org/10.1007/s12253-019-00594-4</mixed-citation></ref><ref id="scirp.108473-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Krstic, M., et al. (2013) KLF4 Expression and Apoptosis-Related Markers in Gastric Cancer. Journal BUON, 18, 695-702.</mixed-citation></ref><ref id="scirp.108473-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, X., et al. (2016) Discovery of Signature Genes in Gastric Cancer Associated with Prognosis. Neoplasma, 63, 239-245. https://doi.org/10.4149/209_150531N303</mixed-citation></ref><ref id="scirp.108473-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, Y., et al. (2018) LASSO-Based Cox-PH Model Identifies an 11-lncRNA Signature for Prognosis Prediction in Gastric Cancer. Molecular Medicine Reports, 18, 5579-5593. https://doi.org/10.3892/mmr.2018.9567</mixed-citation></ref><ref id="scirp.108473-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Xiang, Z., et al. (2019) A Positive Feedback between IDO1 Metabolite and COL12A1 via MAPK Pathway to Promote Gastric Cancer Metastasis. Journal of Experimental &amp; Clinical Cancer Research, 38, Article No. 314. https://doi.org/10.1186/s13046-019-1318-5</mixed-citation></ref><ref id="scirp.108473-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Li, N., et al. (2020) Integrative Analysis of Differential lncRNA/mRNA Expression Profiling in Helicobacter pylori Infection-Associated Gastric Carcinogenesis. Frontiers in Microbiology, 11, 880.</mixed-citation></ref><ref id="scirp.108473-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Niemira, M., et al. (2019) Molecular Signature of Subtypes of Non-Small-Cell Lung Cancer by Large-Scale Transcriptional Profiling: Identification of Key Modules and Genes by Weighted Gene Co-Expression Network Analysis (WGCNA). Cancers (Basel), 12, 37. https://doi.org/10.3390/cancers12010037</mixed-citation></ref><ref id="scirp.108473-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Zhou, L., et al. (2020) Exploring TCGA Database for Identification of Potential Prognostic Genes in Stomach Adenocarcinoma. Cancer Cell International, 20, Article No. 264. https://doi.org/10.1186/s12935-020-01351-3</mixed-citation></ref></ref-list></back></article>